Maximum Dose of Benidipine
The maximum recommended daily dose of benidipine is 8 mg once daily for hypertension in adults, though doses up to 16 mg daily have been studied in patients with chronic kidney disease already receiving angiotensin receptor blockers. 1, 2, 3, 4
Standard Dosing for Hypertension
- Initial dose: 2-4 mg once daily 3, 5
- Maintenance dose: 4-8 mg once daily 1, 2, 3
- Maximum approved dose: 8 mg once daily for standard hypertension treatment 3, 5
The 8 mg once-daily regimen has been extensively validated in elderly Chinese patients with mild-to-moderate hypertension, demonstrating effective blood pressure control with a favorable safety profile over 52 weeks of treatment. 3
Higher Doses in Specialized Populations
In patients with stage 3-5 chronic kidney disease receiving maximum-dose ARBs, benidipine has been titrated up to 16 mg daily to achieve additional blood pressure reduction and antiproteinuric effects. 4 This higher dosing was used specifically in:
- Patients with moderate-to-advanced CKD (stages 3-5) 4
- Patients already on maximum recommended ARB doses 4
- Treatment duration of 6 months with demonstrated safety 4
Dose-Dependent Effects on Aldosterone
The plasma aldosterone concentration reduction appears dose-dependent:
- 4 mg daily: Showed a trend toward PAC reduction but did not reach statistical significance (P = 0.096) 1
- 8 mg daily: Significantly reduced PAC by 13.2% (P = 0.017) independent of blood pressure control 1
This suggests that higher doses within the therapeutic range provide additional cardio-renal protective benefits beyond blood pressure lowering alone. 1
Titration Strategy
Titration should proceed gradually:
- Start at 2-4 mg once daily 3, 5
- Increase to 8 mg once daily to achieve target blood pressure (<140/90 mmHg in non-diabetics, <130/80 mmHg in diabetics) 3
- For patients with CKD on ARBs who require additional blood pressure control, titration up to 16 mg daily may be considered 4
- Add-on therapy with hydrochlorothiazide or metoprolol is permitted if monotherapy is insufficient 3
Safety Profile at Maximum Doses
The 8 mg daily dose demonstrates excellent tolerability:
- Adverse events occurred in only 15.1% of elderly patients over 52 weeks 3
- Only 6 patients (3.9%) discontinued treatment due to drug-related adverse events 3
- Patient compliance averaged 98.7% 3
- No serious adverse events were reported at the 8 mg dose 5
At 16 mg daily in CKD patients, the medication remained well-tolerated over 6 months, though this higher dose should be reserved for patients with advanced kidney disease already on maximal ARB therapy. 4
Clinical Considerations
Benidipine's unique T/L-type calcium channel blocking properties differentiate it from pure L-type blockers like amlodipine, providing additional renoprotective effects through efferent arteriolar dilation and reduction of glomerular pressure. 2, 4 This mechanism supports the use of higher doses (up to 16 mg) specifically in patients with proteinuric kidney disease. 4
Common pitfall: Do not exceed 8 mg daily in standard hypertensive patients without compelling indications such as advanced CKD with proteinuria despite maximal ARB therapy. 3, 4